Comprehensive Literature Review Services
Proven Hybrid Platform and Service OfferingAI-powered systematic, targeted, scoping, and rapid reviews built for pharma and medtech teams who demand scientific rigor, speed, and traceability.
The MadeAi Literature Review Difference
60%
Faster Screening & Extraction
50-60%
Operational Cost Savings
>99%
SME + AI Accuracy
100%
Scalable & Repeatable Success
Evidence Across All Dimensions
MadeAi covers every dimension of evidence that matters to clinical, market access,
and regulatory teams across all major therapeutic categories.
Tailored Stakeholder Reports
Our team delivers literature reviews tailored to the specific needs of regulatory, market access, clinical, and scientific stakeholders.
Health Technology Assessment & Market Access:
HTA submissions (e.g., NICE, IQWiG), Global Value Dossiers (GVD), AMCP dossiers, and payer evidence packages.
Clinical & Evidence Strategy:
Disease Area Reports (DAR), epidemiology studies, treatment landscape analysis, and comparator evaluations.
Scientific Publications & Medical Communications:
Peer-reviewed manuscripts and scientific narratives.
Regulatory & Compliance:
Clinical Evaluation Reports (CER), 510(k)/PMA submissions, PSURs, PMCF, and safety documentation
Human Expertise, Enhanced by AI
Our literature review team combines therapeutic knowledge, regulatory experience, and AI expertise to deliver high-quality, reliable outputs.
Therapeutic Area Experts
Deep clinical expertise across a wide range of therapeutic areas, including but not limited to oncology, rare diseases, CNS, cardiovascular, and immunology.
Regulatory & Market Access
Seasoned specialists with hands-on HTA submission experience across NICE, EMA, FDA, and global payer bodies.
AI-Skilled Domain Specialists
Subject matter experts skilled in AI workflows, combining human judgment with AI efficiency.
MD, PhD & PharmD Professionals
Credentialed clinicians and pharmacologists ensuring clinical validity and scientific rigor at every stage.
Cross-functional Collaboration
Integrated expertise across clinical, regulatory, and commercial functions to ensure evidence is aligned, relevant, and decision-ready.
Case Studies & Scientific Research
Ready to Transform Your Literature Review Program?
Join global pharma and medtech teams who trust MadeAi to accelerate evidence generation without sacrificing scientific rigor or traceability.
FAQ
MadeAi Literature Review Services combine expert literature review specialists with AI-powered workflows to deliver end-to-end support from protocol development through submission-ready deliverables. Life sciences teams can supplement internal resources or fully outsource systematic literature reviews while maintaining scientific rigor and regulatory compliance.
MadeAi experts create tailored, PRISMA-aligned protocols using both therapeutic-area knowledge and AI-assisted search strategy design. This ensures reproducible screening criteria and clear inclusion/exclusion rules from day one, saving HEOR and Medical Affairs teams weeks of iteration.
MadeAi uses structured templates and AI-assisted extraction to pull effect sizes, safety data, and quality-of-life outcomes with ARM-level precision. Human experts validate every data point, producing clean, submission-ready evidence tables for Real-World Evidence (RWE) and Health Technology Assessment (HTA) needs.
MadeAi provides fully formatted reports, PRISMA flow diagrams, evidence tables, and export packages ready for regulatory, payer, or publication use. All deliverables include 96% traceability and are designed to accelerate Value Dossier and Pricing and Reimbursement submissions.
Traceability ensures every screening decision, data point, and synthesis step links back to original sources, which is essential for HTA bodies and regulatory audits. MadeAi achieves 96% traceability across all projects, giving Pharmaceutical Market Access and HEOR teams complete confidence.
MadeAi delivers PRISMA-compliant literature reviews and Global Value Dossiers (GVD) tailored for HTA bodies (NICE, IQWiG) and payer evidence packages. Expert teams produce AMCP dossiers, CER reports, and value narratives with 96% traceability.
MadeAi combines therapeutic-area experts (MD, PhD, PharmD) with AI-assisted screening and dual human validation to meet CER, 510(k), PMA, PSUR, and PMCF standards. All outputs are fully auditable and submission-ready for regulatory compliance.
The team includes therapeutic-area specialists (CNS, oncology, immunology, cardiovascular), regulatory experts (CER, HTA, GVD), and PhD/MD reviewers with extensive industry experience. All leverage the MadeAi platform for efficiency and consistency.